Kawase, K., Yoshida, K., Hara, K., Hidaka, S. and Takeyama, H. (2023) “Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer”, Clinical Medicine Insights, 4(2), pp. 378–386. doi: 10.52845/CMI/2023-4-2-1.